跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAXIGESIC IV paracetamol 1000 mg and ibuprofen (as sodium dihydrate) 300 mg in 100 mL solution for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
MAXIGESIC IV paracetamol 1000 mg and ibuprofen (as sodium dihydrate) 300 mg in 100 mL solution for infusion vial
Approved
STANDARD
MAXIGESIC IV paracetamol 1000 mg and ibuprofen (as sodium dihydrate) 300 mg in 100 mL solution for infusion vial
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
92f7bc034f458667
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
92f7bc034f458667
Product Name
MAXIGESIC IV paracetamol 1000 mg and ibuprofen (as sodium dihydrate) 300 mg in 100 mL solution for infusion vial
Artg Id
301145
Artg Name
MAXIGESIC IV paracetamol 1000 mg and ibuprofen (as sodium dihydrate) 300 mg in 100 mL solution for infusion vial
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2019-07-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/40bf1f993963ad8924b315ddf267b4c7.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7b2290c8c3f9b7bfc3694814123d5e64.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
92f7bc034f458667
Type
Standard
Back to TGA Approvals